Kraków, Poland – 04 May 2017 – Selvita will participate, as well as present, at the upcoming BioTrinity 2017 conference, taking place in London, UK, on May 08 – 10, 2017.
BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK. The conference offers unique networking opportunity with global life science investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to make deals and grow their networks.
Selvita delegates will actively participate in the BioTrinity partnering sessions as well as
dr Wojciech Czardybon, R&D Consulting Director at Selvita,
will present the latest company R&D and corporate updates in the Company Showcase – Early Stage, Therapeutics 1 Track, on Tuesday, May 9, 2:20 PM in the Alsace Room.
Feel invited to join us!
To contact Selvita delegates at BioTrinity, please contact us at: +48 12 297 47 00, firstname.lastname@example.org.
Selvita’s attendance at this conference is subsidized with the funds from the ProBio Małopolska project, which is co-financed by the European Union under the European Regional Development Fund, carried out on the basis of the project co-financing agreement No. RPMP.03.03.01-12-0121 / 16-00. The trip was organized with the assistance of Klaster LifeScience Kraków.